Literature DB >> 3948306

Pharmacokinetics in experimental and clinical chemotherapy.

P Workman.   

Abstract

Mesh:

Substances:

Year:  1986        PMID: 3948306     DOI: 10.1007/bf00256177

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  12 in total

1.  Resistance to adriamycin in multicellular spheroids.

Authors:  R M Sutherland; H A Eddy; B Bareham; K Reich; D Vanantwerp
Journal:  Int J Radiat Oncol Biol Phys       Date:  1979-08       Impact factor: 7.038

Review 2.  Anticancer drug pharmacodynamics.

Authors:  G Powis
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

3.  Dose-response curves after in vivo experimental chemotherapy: influence of route of administration on biological outcomes.

Authors:  J V Moore
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333

4.  The concept of drug dose for in vitro studies with chemotherapeutic agents.

Authors:  K T Wheeler; V A Levin; D F Deen
Journal:  Radiat Res       Date:  1978-12       Impact factor: 2.841

5.  Flow cytometric measurement of total DNA content and incorporated bromodeoxyuridine.

Authors:  F Dolbeare; H Gratzner; M G Pallavicini; J W Gray
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

6.  Immunochemical studies of DNA modified by cis-dichlorodiammineplatinum(II) in vivo and in vitro.

Authors:  B Malfoy; B Hartmann; J P Macquet; M Leng
Journal:  Cancer Res       Date:  1981-10       Impact factor: 12.701

7.  Flow cytometry studies of intracellular adriamycin in multicell spheroids in vitro.

Authors:  R E Durand
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

8.  Cell selection from a murine tumour using the fluorescent probe Hoechst 33342.

Authors:  D J Chaplin; R E Durand; P L Olive
Journal:  Br J Cancer       Date:  1985-04       Impact factor: 7.640

9.  Misonidazole and CCNU: further evidence for a pharmacokinetic mechanism of chemosensitization and therapeutic gain.

Authors:  F Y Lee; P Workman
Journal:  Br J Cancer       Date:  1984-05       Impact factor: 7.640

10.  In vivo combination of misonidazole and the chemotherapeutic agent CCNU.

Authors:  D W Siemann
Journal:  Br J Cancer       Date:  1981-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.